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fa person were to travel back in
time 20 years and walk through
a restaurant, office building, or
airport terminal in the United
States, he might notice one dif-
ference above all others.
Perhaps more than the out-
moded communications tech-
nologies, hairstyles, and clothing, he might
be struck by the prevalence of tobacco
smoke in the air. Not only was the per-
centage of smokers far higher in the
United States 20 years ago, smokers were
also allowed to indulge in their habit virtu-
ally anywhere. While it was known at the
time that smokers jeopardized their own
health, there was little evidence that non-
smokers could be harmed by inhaling the
fumes that floated in the air. Those who
complained about being exposed to sec-
ondhand smoke were often dismissed as
selfish or irrational. That attitude is chang-
ing as one scientific study after another
finds strong associations between a variety
ofhuman illnesses and exposure to what is
now called environmental tobacco smoke
(ETS). Although some scientists insist that
the evidence implicating ETS as a cause of
disease is stronger than the evidence impli-
cating most, ifnot all, other environmental
toxins, cigarette manufacturers continue to
cast doubt on this contention, and the
debate over the link between ETS and
human illness continues.
MountingEvidence
ETS is defined as the sum of sidestream
smoke, which is released from the burning
tip of a cigarette, and mainstream smoke,
which is exhaled by the smoker.
Mainstream smoke and sidestream smoke
are qualitatively similar in composition,
but differ in the concentration of their
constituents because oftheir different com-
bustion characteristics. Sidestream smoke
is a result of less complete combustion
than mainstream smoke and thus contains
considerably higher concentrations of car-
cinogenic and toxic substances.
Tobacco smoke contains more than
4,500 compounds in particle phase. These
compounds include more than 40 known
or suspected human carcinogens and many
toxic agents such as carbon monoxide,
nitrogen oxides, ammonia, acrolein, and
nicotine. Tobacco smoke also contains res-
pirable suspended particles, which contain
dicyclic and polycyclic aromatic hydrocar-
bons, some of which are known animal
carcinogens.
Researchers cite a series of watershed
reports as establishing the link between
ETS and human illness. In 1986, the U.S.
Surgeon General's report, The Health
Consequences ofInvoluntary Smoking,
reviewed 13 spousal studies on passive
smoking and lung cancer, 11 of which
showed a positive association. (Studies of
spouses are often used for epidemiology
studies on the effects of ETS exposure
because of the presumed high level of
exposure a nonsmoking spouse gets from a
smoking spouse.) The report concluded
that ETS is a cause of disease, including
lung cancer, in healthy nonsmokers. That
same year, the National Academy of
Sciences' National Research Council
reached much the same conclusions in
their report, Environmental Tobacco Smoke:
Measuring Exposures and Assessing Health
Effects. Also in 1986, the International
Agency for Research on Cancer completed
a meta-analysis entitled Evaluation ofthe
Carcinogenic Risk of Chemicals to
Humans-Tobacco Smoking. This study
supported a causal relationship between
ETS and lung cancer.
The next important publication was
the U.S. Environmental Protection
Agency's (EPA) 1992 report, Respiratory
Health Effects ofPassive Smoking: Lung
Cancer and Other Disorders. This report
reviewed 30 epidemiological studies on
passive smoking and lung cancer, 24 of
which showed positive associations. The
EPA classified ETS as a known ("Class A")
human carcinogen and calculated that it
contributes to approximately 3,000 deaths
each year in the United States among non-
smokers. The report also documented
causal associations between ETS and lower
respiratory tract infections (such as pneu-
monia and bronchitis), otitis media (mid-
dle ear disease), and exacerbation of asth-
ma in children.
In 1997, the California Environmental
Protection Agency (CalEPA) released a
report entitled Health Effects ofExposure to
Environmental Tobacco Smoke, which com-
prehensively covered studies conducted fol-
lowing the EPA's report. The CalEPA
report confirmed the EPA's findings on
the links between ETS, lung cancer, and
respiratory disease, and also found causal
association with heart disease, retardation
of fetal growth, sudden infant death syn-
drome (SIDS), and nasal sinus cancer.
In December 1998, the Report on
Carcinogens Subcommittee of the Board
of Scientific Counselors of the National
Toxicology Program met in Research
Triangle Park, North Carolina, to discuss
possible classification of ETS as a known
human carcinogen. This classification is
bestowed on compounds for which there is
sufficient evidence ofcarcinogenicity from
studies in humans, indicating a causal rela-
tionship between exposure to the agent,
substance, or mixture and human cancer.
The subcommittee voted unanimously in
favor of classification of ETS as a known
human carcinogen. A meta-analysis on
ETS was prepared for this review, but has
not yet been published. A final report is
expected to be submitted to the secretary
of the Department of Health and Human
Services in late spring.
Determining Exposure to ETS
Assessing the means by which individuals
are exposed to ETS and the rates at which
they are exposed is a complex task. By defi-
nition, ETS is diluted in air, and in any
given environment will likely vary in con-
centration from barely detectable levels to
levels nearly as high as those experienced
by active smokers. The amount of smoke
one may be exposed to in a microenviron-
ment varies with length of exposure, the
number of cigarettes being smoked, the
ventilation system in the building, and the
adsorptive qualities of structural compo-
nents, draperies, and furniture.
The most direct method of assessing
exposure is through the use ofarea or per-
sonal monitoring equipment. These
devices typically sample air for respirable
suspended particles and vapor-phase nico-
tine. Personal monitoring devices worn by
study subjects are the most accurate, as
they account for the subjects' movement in
and out of different microenvironments.
However, personal monitoring devices do
not measure all ofthe components ofETS.
They are also relatively expensive, and thus
not feasible for studies with large sample
sizes.
Exposure to ETS can be assessed indi-
rectly through the use ofmathematical for-
mulas and mass balance models. These
tools take into account the concentrations
of tobacco smoke in different microenvi-
ronments and the amount oftime spent by
individuals in each microenvironment.
Mass balance models have yielded results
reasonably close to actual measured levels
ofETS for single rooms.
In epidemiological studies, question-
naires and interviews are the primary tools
used to determine and quantify exposure to
ETS. Questionnaires can provide detailed
information on several factors. They may
measure ETS source strength-the level of
smoke in the air to which people are
exposed, usually measured in micrograms
of nicotine per cubic meter of air (pg/m3).
They may gather retrospective exposure
information that is not available through
direct measurement or biomarkers (current
biomarkers can only measure exposure to
ETS over the previous 7-40 hours) or
information on long-term exposure, which
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1986 The U.S. Surgeon General
publishes a report, The Health
Consequences ofInvoluntary Smoking,
that concludes that ETS is a cause ofdis-
ease, including lung cancer, in non-
smokers.
The National Academy of Sciences'
National Research Council also con-
cludes that ETS causes a variety of dis-
eases in its report Environmental Tobacco
Smoke: MeasuringExposures andAssessing
Health Effects.
1992 The EPA publishes a report,
Respiratory Health Effects ofPassive
Smoking: Lung Cancer and Other
Disorders, that calculates that ETS con-
tributes to approximately 3,000 deaths
per year ofnonsmokers.
The EPA also classifies ETS as a
known ("Class A") human carcinogen.
199441995The Occupational
Safety and Health Administration con-
ducts hearings on the proposed regula-
tion of indoor air quality, including
exposure to ETS.
1997 President Clinton signs an
executive order that bans smoking in fed-
eral facilities. Forty-three states currently
restrict smoking in government work-
places; 23 states have extended these lim-
itations to private-sector workplaces.
The California Environmental Protec-
tion Agency publishes Health Effects of
Exposure to Tobacco Smoke, which finds
links between ETS and lung cancer, respi-
ratory disease, heart disease, retardation of
fetal growth, SIDS, and nasal sinus cancer.
1998 A federal judge in North
Carolina overturns the EPA dassification
ofETS as a known human carcinogen in
a suit brought by tobacco companies.
The Report on Carcinogens Sub-
committee of the National Toxicology
Program votes unanimously to recom-
mend listing of ETS in the report as a
known human carcinogen.
is relevant for many health effects. They
can record simultaneous information on
time-activity patterns (how long a person is
in a smoky room) and modifying environ-
mental factors, including amount of venti-
lation. They can also gather information on
possible confounders, including diet, con-
sumption ofalcohol, and exposure to other
pollutants at home and in the workplace.
Questionnaires are also the least expensive
method ofgathering information.
Concerns about questionnaires include
the lack of a commonly accepted format,
lack of a common standard by which to
validate questionnaires, and the possibility
of misclassification of exposure.
Misclassification can occur in a variety of
ways, including the respondents' failure to
recall exposure precisely, intentional false
reporting of exposure, and biased recall of
the amount of smoke to which they were
exposed. The latter has become a more
pertinent issue in recent years as the public
awareness of the adverse health effects of
ETS has increased.
Various biomarkers can also be used to
gauge human exposure to ETS. Biomarkers
can serve to validate questionnaire respons-
es by indicating recent exposure to ETS,
and they add to the plausibility of associa-
tions between involuntary smoking and
disease documented in epidemiological
studies. However, no biomarker is effective
for measuring cumulative past exposure.
The most sensitive and specific markers
are nicotine and its metabolite cotinine.
Cigarettes contain about 1.0-7.0% nico-
tine by weight, ofwhich 15-25% is emit-
ted in mainstream smoke and 40% is emit-
ted in sidestream smoke. A number of
studies have either assumed or concluded
that body fluid nicotine levels can serve as
a quantitative indicator of ETS exposure.
The circulating half-life of nicotine is gen-
erally less than 2 hours. Therefore, it can
only be relied upon to detect recent expo-
sures. Cotinine, however, has a half-life in
the blood, urine, or plasma of adult non-
smokers of 7-40 hours. Hence, cotinine
levels provide information about more
chronic exposure to tobacco smoke in both
smokers and nonsmokers.
Concerns have been raised about the
nonspecificity of both nicotine and coti-
nine as biomarkers of ETS exposure, as
nicotine is found in various common foods
including tomatoes, potatoes, eggplant,
and certain teas. The amounts of nicotine
found in such foods, however, are minus-
cule relative to the amount found in ETS,
and massive amounts of such foods would
have to be consumed to equal the exposure
gained from ETS. Critics have also pointed
to the fact that few studies have assessed
cotinine levels in nonsmokers relative to
airborne nicotine, and they question the
biomarker's accuracy in determining quan-
titative exposure to ETS.
Other compounds including carbon
monoxide, thiothers, thiocyanate, and
tobacco-specific N-nitrosamines have been
studied as possible biomarkers for ETS
exposure. However, all but tobacco-specific
N-nitrosamines have complications that
limit their potential as reliable biomarkers.
Recently, the presence of nicotine in
human hair has been used as a biomarker
of ETS exposure. Human hair has a high
affinity for airborne nicotine, and chamber
studies have revealed a linear relationship
between the extent of airborne nicotine
exposure and its adhesion to hair strands.
This relationship has been measured as
much as 4-6 weeks after exposure.
Degrees ofExposure
Given that the percentage of smokers has
declined and regulations increasingly limit
the areas where people can smoke, the
question arises as to what degree people in
the United States are exposed to ETS.
Levels of exposure in the numerous pub-
lished studies have varied tremendously
over time and by location. However, most
have confirmed that nonsmokers working
and living with smokers are exposed to sig-
nificant levels of ETS. In its 1992 report,
the EPA stated that smokers comprise
approximately 26% of the U.S. adult pop-
ulation, "causing nearly universal exposure
to at least some ETS." An article by James
Pirkle and colleagues, published in the 24
April 1996 issue of the Journal ofthe
American MedicalAssociation, reviewed the
findings of the Third National Health and
Nutrition Examination Survey, conducted
between 1988 and 1991. This study used
cotinine as a biomarker for ETS exposure.
Pirkle found that 43% of children aged 2
months to 11 years lived in a home with at
least one adult smoker, and 37% of adult
nonsmokers either lived in a home with at
least one smoker or were exposed to ETS
at work. Of all nonsmokers, 87.9% had
detectable levels ofserum cotinine.
In 1994 and 1995, the Occupational
Safety and Health Administration con-
ducted hearings on the proposed regulation
ofindoor air quality, including exposure to
ETS. Some witnesses indicated that expo-
sures to ETS in the home exceeded those
in the workplace, while others maintained
that workplace exposures were comparable
to those in the home. Subsequently, S.
Katherine Hammond, an associate profes-
sor ofenvironmental health sciences at the
University of California at Berkeley, and
colleagues reviewed relevant studies on
Volume 107, Number 4, April 1999 * Environmental Health Perspectives A 198Focus * Double Exposure
ETS concentrations in the workplace [see
Environmental Health Perspectives
107(suppl 2)]. She found that significant
numbers of U.S. workers are exposed to
hazardous levels of ETS, but that policies
that ban smoking in the workplace are
effective in lowering exposure to pollutants.
Hammond measured mean concentra-
tions of nicotine in workplaces where
smoking was allowed at 2-6 pg/m3 in
offices, 3-8 pg/m3 in restaurants, and 1-6
pg/mi3 in blue-collar workplaces. In all
workplaces in which smoking was banned,
nicotine concentrations measured less than
1 pg/m3. Mean concentrations of nicotine
in the homes of smokers have been mea-
sured at 1-3 pg/mi3.
Most recently, the sampling and analy-
sis group at Tennessee's Oak Ridge
National Laboratory, led by RogerJenkins,
conducted studies ofworkers in avariety of
occupations [see Environmental Health
Perspectives 107(suppl 2)]. Using measure-
ments from personal monitoring devices,
Jenkins found that general workplace
exposures were much lower than those esti-
mated in earlier studies. For example, the
daily uptake ofnicotine was 20% ofearlier
published estimates of 15 pg/m3 for the
most highly exposed workers, versus the
Occupational Safety and Health
Administration's 1994 estimates of50-100
pg/m3. "It is clear that while a small major-
ity ofworkers are exposed to higher levels
of ETS, the vast majority just are not
exposed to a lot of ETS," Jenkins says.
Questions have been raised aboutJenkins's
study concerning its accuracy, the quality
control of the study, and the potential for
bias-the study was funded by the Center
for Indoor Air Research, which is heavily
funded by the tobacco companies.
However, Jenkins says that the Oak Ridge
laboratory had full authority over all
aspects ofthe study, and he stands by it as
the most comprehensive and representative
exposure study to date.
RiskAssessments
Assessing risks associated with exposure to
ETS is a daunting task. As with active
smoking, a wide variety of ailments rang-
ing from otitis media to lung cancer are
associated with exposure to ETS. Many of
these diseases have a complex etiology and
all have multiple causes, often making
causal relationships difficult to determine.
Epidemiological studies form the basis
of most risk assessments associating ETS
exposure with various disease end points.
Both cohort and case-control studies have
been used. In cohort studies, the occur-
rence ofan illness over time in nonsmokers
is assessed in relation to ETS exposure. In
the more common case-control studies,
nonsmoking individuals who have been
exposed to ETS and who have an illness
suspected ofbeing caused by ETS are com-
pared to an appropriate control group.
Determining the degree ofexposure to
ETS and separating its effects from numer-
ous other potential causes is central to
accurately assessing risk. Findings of epi-
demiological studies have been challenged
due to such factors as the suitability of
questionnaires for accurately determining
past exposure, small sample size, and selec-
tion bias. In many cases, epidemiological
studies provide varying and imprecise
degrees of risk, and exposures have not
been characterized for large and representa-
tive population samples. However, these
factors have been considered by various
governmental and nongovernmental agen-
cies in analyzing and weighing the evi-
dence from numerous epidemiological
studies on the health effects of ETS expo-
sure. Such agencies have been confident in
assigning causal relationships where the
studies showed consistent results and
where there was a biologically plausible
association with ETS and a particular end
point.
ETS and Cancer
Based on the clear connections between
active smoking and development of lung
cancer, numerous studies have examined
the relationship between ETS exposure
and lung cancer. By 1986, accumulated
evidence led the International Agency for
Research on Cancer, the National Research
Council, and the U.S. Surgeon General
each to conclude that exposure to ETS
increases the risk of lung cancer in non-
smoking adults. In 1992, the EPA released
a meta-analysis ofthe 31 published studies
at that time on ETS and lung cancer, and
concluded that nonsmokers living with
smokers have a 19% greater risk of con-
tracting lung cancer than nonsmokers who
don't livewith smokers.
The EPA's report was criticized for a
host ofreasons, including possible misclas-
sification ofsmokers as nonsmokers (which
would result in an understatement of the
effect), possible publication bias in favor of
studies showing a positive association, and
difficulty in obtaining risk estimates
adjusted for underreporting ofexposure to
ETS. A series of population-based studies
designed to address some of these weak-
nesses was in progress at the time of the
release of the EPA's meta-analysis. These
studies subsequently found results similar
to those of the EPA. Based on these more
recent findings, CalEPA concluded in its
1997 report that exposure to ETS causes
about a 20% gteater risk of lung cancer
among nonsmokers.
The biological plausibility of ETS
exposure leading to lung cancer was
enhanced in a recent study by William
Parsons, a phys-ician at Sainte Anne's
Hospital in Sainte-Anne-de-Bellevue,
Quebec, working in cooperation with
Stephen Hecht of the University of
Minnesota Can'cer Center in Minneapolis.
The study, publlshed in the March 1998
issue of Cancer Epidemiology, Biomarkers
and Prevention, revealed the presence of
significant levels of NNAL-Gluc, a
metabolite ofa kaiown lung carcinogen, in
the urine of nonsmoking hospital workers
exposed to ETS.
Exposure to ETS has also been exam-
ined as a cause ofother cancers, including
breast, cervical, and nasal cancer. Some sci-
entists believe an association between ETS
exposure and breast cancer is plausible
because carcinogens in tobacco smoke and
their metabolites are absorbed systemically,
and have been detected in the nipple aspi-
rates ofnonlactating women. Four analyti-
cal epidemiological studies were reviewed
by CalEPA for an association between ETS
exposure and breast cancer. The agency
concluded that, while all four studies sug-
gested an increited risk of breast cancer
from exposure to ETS, the results cannot
be considered conclusive because three of
the studies showed either no association
between active snioking and breast cancer
or a weaker association for active smoking
than for passive smoking-findings that
have yet to be reconciled.
It appears that some people may be
genetically more susceptible than others to
breast cancer as a result of exposure to
tobacco smoke. Aromatic amines are
detoxified or bioactivated by xenobiotic
metabolizing enzymes, including N-acetyl-
transferase. In a study published in the 13
November 1996 issue oftheJournal ofthe
American Medical Association, Christine
Ambrosone, a research epidemiologist with
the National Center for Toxicological
Research in Jefferson, Arizona, and col-
leagues found that postmenopausal women
who exhibit a certain N-acetyltransferase
polymorphism (slow acetylators) have a
decreased capacity to detoxify carcinogenic
aromatic amines in cigarette smoke. This
may make such Women who smoke or who
are exposed to tobacco smoke more suscep-
tible to breast cancer.
The CalEPA report reviewed one
cohort and three case-control studies
investigating the relationship between ETS
and cervical cancer. A positive but non-
significant association was reported in the
cohort study and a significant, positive
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* At least six studies have reported lower birth weights for infants of nonsmoking
mothers exposed to ETS during pregnancy.
* Several studies have linked ETS exposure in pregnant women with growth
retardation and congenital malformations in their babies.
* Studies have shown a significant association-up to 40% increased risk-of
suddent infant death syndrome (SIDS) in infants exposed to ETS.
* Extensive epidemiological evidence links ETS to an increased risk of lower
respiratory tract illnesses such as bronchitis and pneumonia in children ofparents
who smoke.
* Reports of the U.S. Surgeon General have concluded that exposure to ETS can
reduce lung function in children. Increasing evidence shows that ETS may
contribute significantly to childhood asthma.
* The U.S. Surgeon General, the Environmental Protection Agency, and the
National Research Council have all concluded that there is an association between
exposure to ETS and middle ear disease in children.
association was found in two of the
case-control studies. In the third, exposure
ofspouses ofsmokers to ETS was associated
with an increased risk ofcervical cancer and
intraepithelial neoplasia in nonsmokers,
but the result was of borderline statistical
significance.
Based on data from the one cohort and
two case-control studies, CalEPA conclud-
ed that there is strong evidence that expo-
sure to ETS increases the risk ofnasal can-
cer in nonsmoking adults. The studies
showed an increased risk ranging from 1.7
to 3.0.
Not only does ETS by itself appear to
be a carcinogen, but in combination with
other agents it may magnify the risk ofcer-
taini canicers exponentially. Many smokers
drink alcohol, and studies have shown that
alcohol and tobacco smoke taken together
combine in a multiplicative rather than
additive fashion to increase the risk of oral
and pharyngeal cancer. In a study pub-
lished in the 1 June 1988 issue of Cancer
Research, William Blot, then chief of the
Biostatistics Branch at the National Cancer
Institute in Bethesda, Maryland, and col-
leagues found that the risk ofsuch cancers
increased 35-fold among those who
smoked two or more packs ofcigarettes per
day and drank more than four alcoholic
drinks per day. Although these studies
examined the relationship between alcolhol
and active smoking, the potential exists for
similar risks associated specificallIy with
ETS exposure.
While research on i 1 S and adult
health has focused primarily oni canicer risk,
nearly two dozen studies have examined
the association between ET1S and cardio-
vascular disease. In its 1997imeta-analysis
of these studies, CalEPA concluded that
there is a 3000 risk of coronarx heart dis-
ease due to exposure to ETIS. lThe
American Heart Association s C ouncil oni
Cardiopulmonary and C ritical C are has
also concluded that ETS both inicreases the
risk of heart disease and is a major pre-
ventable cause of cardiovasculiar disease
and death.
ETS and Children's Health
The effect of ETS on infanits and childreni,
who are frequently unable to avoid expo-
sure and who are generally more suscepti
ble to environmentally related disease thani
adults, is of particular concet-tn. NumerouLs
studies have demonistrated associatiolns
between exposure to EITS and a variety of
childhood illnesses, and the damaging
effects appear to begin prior to birth. At
least six studies have reported lower birth
weights for infants ofnonsmokinig mothers
exposed to ETS during pregnanicy. Other
studies have suggested ant association
between ETS exposure in pregnant women
and growth retardation and congetital
malformations in their offspring.
Postnatal exposure to FTS also appears
to have deleterious effects oni the health of
young children, according to a chapter on
ETS in Environmental Toxicanits (in press)
by Jonathan Samet anid Sophia Wang,
researchers at the School of Hygiene and
Public Health at Johns Hopkins Universitxy
in Baltimore, Maryland. Tro date, 10 stud-
ies have addressed the associatioil betweeni
SIDS and ETS exposure. Most of these
studies have shown a significant associa-
tion- as much as a 40% greater risk of
SIDS although in somCe cases it ws
impossible to separate the effects of expo-
sure to ETS from those of maternal smok-
ing during pregnancy. According to the
CalEPA report, there is 'compelling csi-
dence that postnatal ETS exposure of the
child is an independent risk factor foi
SIDS."
Extensive epidemiological evidence
from throughout the developing world
links ETS exposure to increased risk of
severe lower respiratory tract illness in chil-
dren. These studies indicate that the risk of
developing lower respiratory illnesses
including bronchitis and pneumLionia is
1.5-2.0 times higher during the first year
of life for young children whose mothers
smoke than for those whose mothers do
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not smoke. ETS is presumed to increase
the risk of infection by respiratory
pathogens, primarily through lowering
defenses against respiratory viruses rather
than through a direct toxic effect, although
the mechanism by which infection occurs
is not known.
Data from numerous surveys demon-
strate a greater frequency ofcommon res-
piratory symptoms, including coughing,
phlegm, and wheezing, among children of
smokers. One of the most common
chronic diseases of childhood is asthma.
While the underlying mechanisms remain
to be identified, the epidemiological evi-
dence linking ETS exposure and child-
hood asthma is mounting. "Exposure to
ETS could plausibly contribute to the
onset ofasthma or exacerbate the status of
children having that disease," says Samet.
"Inflammation of the airways is a hall-
mark ofasthma, and inhalation and depo-
sition ofETS could sustain or increase the
degree ofinflammation."
Several reports, including the 1984 and
1986 reports ofthe U.S. Surgeon General,
have concluded that exposure to ETS can
reduce the lung function of children. A
1983 longitudinal study by Ira Tager, a
professor ofepidemiology at the School of
Public Health at the University of
California at Berkeley, and colleagues has
shown that lifelong exposure ofa child to a
mother who smokes reduces growth ofthe
FEV1, a measure of lung capacity, by as
much as 10.7%.
One ofthe most frequent diseases diag-
nosed in children at outpatient facilities is
otitis media, an illness that can lead to
varying degrees of hearing loss. The U.S.
Surgeon General's Office, the National
Research Council, and the EPA have
reviewed the literature on ETS and otitis
media, and all have concluded that there is
an association between ETS exposure and
this disease. A 1997 meta-analysis by
Derek Cook and David Strachan, profes-
sors ofepidemiology at the Department of
Public Health Sciences at St. George's
Hospital in London, concluded that a
child has a 48% greater risk ofotitis media
if either parent smokes. The study
appeared in the January 1998 issue of
Thorax.
Public Action and Reaction
Numerous individual studies and meta-
analyses from around the world have come
to the conclusion that exposure to ETS is a
health hazard. As a result ofthese findings,
the EPA has classified ETS as a Class A
carcinogen (although the classification was
overturned in a lawsuit filed by members
ofthe tobacco industry), and the National
Toxicology Program has recommended
such an action. Smoking has been banned
from many public facilities, workplaces,
and modes of transportation including all
domestic and international flights offered
by U.S. carriers. In many other facilities,
smokers have been confined to designated
areas. While these actions are popular with
the nonsmoking public, they remain con-
troversial, and the science on which they
are based continues in part to be scruti-
nized and debated.
A number of scientists, particularly
those in the employ oftobacco companies,
remain skeptical about the association
between levels ofETS actually encountered
by the nonsmoking public and serious ill-
ness. They have criticized scientific jour-
nals for failing to publish negative findings
and meta-analyses or for disregarding those
that are published. They criticize many of
the epidemiological studies for declaring
causal associations based on marginal odds
ratios, or ratios that, ifadjusted for relevant
biases such as diet and misclassification,
would be rendered insignificant.
"The problem with epidemiological
studies is that they compare people with
different lifestyles, and that makes it
almost impossible to tease out the factors
that lead to disease," says Chris Coggins,
senior vice president of science and tech-
nology for Lorillard Tobacco Company.
"For example, we know that smokers also
tend to have poorer diet, exercise less, and
drink more alcohol than nonsmokers. You
can generate a hypothesis from [epidemio-
logical] studies . . . but you can't prove
anything. The studies related to ETS expo-
sure and lung cancer are particularly weak.
The results are all over the map."
Jennifer Jinot, an environmental sci-
entist with the EPA and coauthor of the
agency's 1992 report, counters that the
various studies do prove a connection
between ETS and cancer, among other
illnesses. "We did a meta-analysis, but we
looked at the data in a number of differ-
ent ways," she says. "We were particularly
influenced by the dose-response relation-
ship. We saw a consistently increasing
risk [of disease] with increasing [ETS]
exposure, regardless of the confounding
factors."
The limitations of epidemiological
studies have placed increased importance
on animal, genotoxicity, and mechanistic
studies in which conditions can be tightly
controlled and results observed in a rela-
tively short period of time. In its delibera-
tions on classifying ETS as a known
human carcinogen, the National
Toxicology Program has shown consider-
able interest in recent studies by Hanspeter
Witschi and colleagues at the Institute for
Toxicology and Environmental Health at
the University of California at Davis that
exposed male mice to sidestream smoke.
These animals showed a significant
increase in lung tumor multiplicity under
some circumstances, but not under others.
Critics, including Coggins, contend that
Witschi's studies did not use a reasonable
surrogate of ETS, exposed test animals to
unrealistically high levels of respiratory
particles, and relied on only one strain of
mouse, a strain known for its propensity to
develop spontaneous lung neoplasms.
Coggins contends there are other well-
designed studies exposing rats to ETS that
have found no increase in lung carcinogen-
esis, including one by Hans-Jurgen
Haussman of the INBIFO research center
in Koln, Germany, published in the July
1998 issue ofInhalation Toxicology.
While neither epidemiological nor ani-
mal studies have revealed unequivocal
proofofthe link between ETS and disease,
the issue remains very much alive in the
nation's boardrooms, legislatures, and
courts. In 1997, flight attendants from
U.S. airlines wrested a $300 million settle-
ment from five major tobacco companies
in a class action suit alleging illness from
exposure to ETS on airline flights. No
doubt other suits will follow. Such actions,
coupled with public demands for a health-
ful environment, will continue to generate
the need for more definitive answers on the
connection between ETS and human
health.
John Manuel
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